Transcriptomic Analyses of Pretreatment Tumor Biopsy Samples, Response to Neoadjuvant Chemoradiotherapy, and Survival in Patients With Advanced Rectal Cancer

Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer

(2022) Adele M. Nicolas et al.   CANCER CELL

Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability–High Locally Advanced Rectal Cancer

(2022) Hideaki Bando et al.   CLINICAL CANCER RESEARCH

Tumor-Infiltrating PD-1+ Immune Cell Density is Associated with Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer

(2022) Yusuke Kitagawa et al.   Clinical Colorectal Cancer

IFNγ signaling integrity in colorectal cancer immunity and immunotherapy

(2021) Wan Du et al.   Cellular & Molecular Immunology

Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

(2021) Osama E. Rahma et al.   JAMA Oncology

Validation of Gene Expression-Based Predictive Biomarkers for Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

(2021) Tomoyuki Momma et al.   Cancers

A diagnostic biopsy-adapted immunoscore predicts response to neoadjuvant treatment and selects patients with rectal cancer eligible for a watch-and-wait strategy

(2020) Carine El Sissy et al.   CLINICAL CANCER RESEARCH

Cytotoxic CD8+ T cells in cancer and cancer immunotherapy

(2020) Hans Raskov et al.   BRITISH JOURNAL OF CANCER

Combined prognostic value of CD274 (PD-L1)/PDCDI (PD-1) expression and immune cell infiltration in colorectal cancer as per mismatch repair status

(2019) Maarit Ahtiainen et al.   MODERN PATHOLOGY

Immunogenomic profiles associated with response to neoadjuvant chemoradiotherapy in patients with rectal cancer

(2019) T. Akiyoshi et al.   BRITISH JOURNAL OF SURGERY

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

(2018) Franck Pagès et al.   LANCET

A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade

(2018) Daniela S. Thommen et al.   NATURE MEDICINE

Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial

(2017) Eric Rullier et al.   LANCET

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

(2017) Pornpimol Charoentong et al.   Cell Reports

Molecular Biology: Are We Getting Any Closer to Providing Clinically Useful Information?

(2017) Georgios Karagkounis et al.   Clinics in Colon and Rectal Surgery

DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics

(2016) Nicole de Rosa et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer

(2016) Milou H. Martens et al.   JNCI-Journal of the National Cancer Institute

Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis

(2016) Andrew G Renehan et al.   LANCET ONCOLOGY

Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer

(2016) Yaqi Li et al.   Molecular Cancer

Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer

(2016) Milou H. Martens et al.   JNCI-Journal of the National Cancer Institute

Removing batch effects from purified plasma cell gene expression microarrays with modified ComBat

(2015) Caleb K Stein et al.   BMC BIOINFORMATICS

A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients

(2015) Marco Agostini et al.   CANCER BIOLOGY & THERAPY

Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity

(2015) Michael S. Rooney et al.   CELL

The consensus molecular subtypes of colorectal cancer

(2015) Justin Guinney et al.   NATURE MEDICINE

The Molecular Signatures Database Hallmark Gene Set Collection

(2015) Arthur Liberzon et al.   Cell Systems

Can a Biomarker-Based Scoring System Predict Pathologic Complete Response After Preoperative Chemoradiotherapy for Rectal Cancer?

(2014) Hyuk Hur et al.   DISEASES OF THE COLON & RECTUM

Tumor Regression Grading After Preoperative Chemoradiotherapy for Locally Advanced Rectal Carcinoma Revisited: Updated Results of the CAO/ARO/AIO-94 Trial

(2014) Emmanouil Fokas et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparison of Tumor Regression Grade Systems for Locally Advanced Rectal Cancer After Multimodality Treatment

(2014) Atthaphorn Trakarnsanga et al.   JNCI-Journal of the National Cancer Institute

World Medical Association Declaration of Helsinki

(2013)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Identification of a Biomarker Profile Associated With Resistance to Neoadjuvant Chemoradiation Therapy in Rectal Cancer

(2011) Julio Garcia-Aguilar et al.   ANNALS OF SURGERY

Pretreatment Transcriptional Profiling for Predicting Response to Neoadjuvant Chemoradiotherapy in Rectal Adenocarcinoma

(2011) K. H. Brettingham-Moore et al.   CLINICAL CANCER RESEARCH

Leukocyte composition of human breast cancer

(2011) B. Ruffell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Appropriate Use and Reporting of Uncontrolled Case Series in the Medical Literature

(2010) John H. Kempen   AMERICAN JOURNAL OF OPHTHALMOLOGY

ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking

(2010) Matthew D. Wilkerson et al.   BIOINFORMATICS

High Ki67, Bax and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction

(2009) M Kikuchi et al.   BRITISH JOURNAL OF CANCER